MET – MetLife, Inc.
MET — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.35
Margin Of Safety %
43
Put/Call OI Ratio
1.83
EPS Next Q Diff
EPS Last/This Y
5.05
EPS This/Next Y
1.15
Price
67.7
Target Price
91.44
Analyst Recom
1.9
Performance Q
-16.47
Upside
53.1%
Beta
0.74
Ticker: MET
16 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | MET | 73.25 | 1.51 | 0.94 | 116978 |
| 2026-03-04 | MET | 73.35 | 1.62 | 2.60 | 123821 |
| 2026-03-05 | MET | 72.94 | 1.63 | 7.04 | 124147 |
| 2026-03-09 | MET | 70.72 | 1.65 | 2.33 | 125902 |
| 2026-03-10 | MET | 70.6 | 1.64 | 1.01 | 126404 |
| 2026-03-11 | MET | 69.96 | 1.65 | 1.44 | 123545 |
| 2026-03-12 | MET | 68.74 | 1.64 | 2.79 | 127046 |
| 2026-03-17 | MET | 69.32 | 1.60 | 1.10 | 128404 |
| 2026-03-18 | MET | 68.57 | 1.66 | 21.29 | 119044 |
| 2026-03-19 | MET | 68.6 | 1.73 | 1.42 | 122292 |
| 2026-03-20 | MET | 68.55 | 1.66 | 1.61 | 119817 |
| 2026-03-23 | MET | 69.2 | 1.92 | 0.90 | 105345 |
| 2026-03-24 | MET | 69.88 | 1.87 | 0.25 | 107845 |
| 2026-03-25 | MET | 70.4 | 1.84 | 0.43 | 108548 |
| 2026-03-26 | MET | 69.76 | 1.81 | 5.18 | 109425 |
| 2026-03-27 | MET | 67.71 | 1.83 | 0.32 | 110565 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
16 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | MET | 72.09 | 11.9 | - | 9.82 |
| 2026-03-02 | MET | 73.26 | 11.8 | - | 9.82 |
| 2026-03-03 | MET | 72.65 | 11.8 | - | 9.82 |
| 2026-03-04 | MET | 73.32 | 11.8 | - | 9.82 |
| 2026-03-05 | MET | 72.95 | 12.0 | - | 9.80 |
| 2026-03-06 | MET | 71.81 | 12.0 | - | 9.80 |
| 2026-03-09 | MET | 70.75 | 12.0 | - | 9.80 |
| 2026-03-10 | MET | 70.57 | 12.0 | - | 9.80 |
| 2026-03-11 | MET | 69.96 | 12.0 | - | 9.80 |
| 2026-03-12 | MET | 68.76 | 12.0 | - | 9.80 |
| 2026-03-13 | MET | 67.97 | 12.0 | - | 9.80 |
| 2026-03-17 | MET | 69.31 | 12.0 | - | 9.80 |
| 2026-03-18 | MET | 68.58 | 12.0 | - | 9.80 |
| 2026-03-19 | MET | 68.60 | 12.0 | - | 9.80 |
| 2026-03-20 | MET | 68.56 | 12.0 | - | 9.80 |
| 2026-03-23 | MET | 69.19 | 12.0 | - | 9.80 |
| 2026-03-24 | MET | 69.89 | 12.0 | - | 9.80 |
| 2026-03-25 | MET | 70.39 | 12.0 | - | 9.80 |
| 2026-03-26 | MET | 69.75 | 12.0 | - | 9.80 |
| 2026-03-27 | MET | 67.70 | 12.0 | - | 9.79 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | MET | 0.00 | -1.26 | 1.89 |
| 2026-03-02 | MET | 0.00 | -0.23 | 1.89 |
| 2026-03-03 | MET | 0.00 | -0.23 | 1.89 |
| 2026-03-04 | MET | 0.00 | -0.23 | 1.89 |
| 2026-03-05 | MET | 0.00 | -0.23 | 1.89 |
| 2026-03-06 | MET | 0.00 | -0.23 | 1.89 |
| 2026-03-09 | MET | 0.00 | -0.32 | 1.89 |
| 2026-03-10 | MET | 0.00 | -0.32 | 1.89 |
| 2026-03-11 | MET | 0.00 | -0.32 | 2.04 |
| 2026-03-12 | MET | 0.00 | -0.32 | 2.04 |
| 2026-03-13 | MET | 0.00 | -0.32 | 2.04 |
| 2026-03-17 | MET | 0.00 | -0.25 | 2.04 |
| 2026-03-18 | MET | 0.00 | -0.25 | 2.04 |
| 2026-03-19 | MET | 0.00 | -0.25 | 2.04 |
| 2026-03-20 | MET | 0.00 | -0.25 | 2.04 |
| 2026-03-23 | MET | 0.00 | -0.23 | 2.04 |
| 2026-03-24 | MET | 0.00 | -0.23 | 2.04 |
| 2026-03-25 | MET | 0.00 | -0.23 | 2.35 |
| 2026-03-26 | MET | 0.00 | -0.23 | 2.35 |
| 2026-03-27 | MET | 0.00 | -0.23 | 2.35 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
2.49
Avg. EPS Est. Current Quarter
2.2
Avg. EPS Est. Next Quarter
2.49
Insider Transactions
Institutional Transactions
-0.23
Beta
0.74
Average Sales Estimate Current Quarter
19195
Average Sales Estimate Next Quarter
19681
Fair Value
97.14
Quality Score
62
Growth Score
73
Sentiment Score
89
Actual DrawDown %
24
Max Drawdown 5-Year %
-35.1
Target Price
91.44
P/E
14.37
Forward P/E
6.19
PEG
0.53
P/S
0.57
P/B
1.56
P/Free Cash Flow
2.44
EPS
4.71
Average EPS Est. Cur. Y
9.79
EPS Next Y. (Est.)
10.94
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
4.12
Relative Volume
1.12
Return on Equity vs Sector %
-0.3
Return on Equity vs Industry %
-5.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
◆
MET
Financial
$67.70
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
15/25
Volume
4/15
Valuation
18/20
TP/AR
2/10
Options
2/10
RSI
33.7
Range 1M
1.7%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
14/25
Growth
12/30
Estimates
6/20
Inst/Vol
2/15
Options
6/10
EPS Yr
10.8%
EPS NY
11.8%
52W%
12.8%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+147.8% upside
Quality
4/30
Valuation
25/30
Growth
9/25
Stability
6/10
LT Trend
4/5
Upside
+147.8%
Quality
62
MoS
43%
Click a card to see score breakdown
Full Analysis →
Sector: Financial Services
Industry: Insurance - Life
Employees: 46000
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
MET
Latest News
—
Caricamento notizie per MET…
stock quote shares MET – MetLife, Inc. Stock Price stock today
news today MET – MetLife, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MET – MetLife, Inc. yahoo finance google finance
stock history MET – MetLife, Inc. invest stock market
stock prices MET premarket after hours
ticker MET fair value insiders trading